Patients using semaglutide benefit from developing new routines, managing stress, identifying triggers for overeating, and building a strong support network
Protein intake becomes critical on tirzepatide because the dramatic appetite reduction can lead to inadequate protein consumption, which accelerates muscle loss during rapid weight loss
Despite the increase in GLP-1s, our study shows that obesity remains undertreated, with only about 9.5% of the relevant population undergoing treatment with GLP-1s or MBS. GLP1 Use Spikes as MBS Use Drops Using IQVIA PharMetrics Plus With Mortality data, the researchers evaluated 11.7 million adults with at least one diagnosis of overweight, obesity, or diabetes and continuous medical and pharmaceutical coverage by commercial, Medicaid, and Medicare Advantage insurance plans from 2022 to 2025
Pen innovation continues: Novo Nordisks FlexTouch and Eli Lillys KwikPen incorporate tactile feedback that reduces dosing errors
Der Artikel gibt erste Anhaltspunkte, kann aber veraltet sein